Double-blind, Randomized, Dose-escalating, Placebo-controlled Study to Assess Pharmacokinetics, Safety, and Tolerability of XC-8 After Single and Multiple Oral Doses in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 19 May 2017
At a glance
- Drugs Histamine glutarimide (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors EURRUS BIOTECH
- 17 May 2017 Status changed from recruiting to completed.
- 14 Sep 2016 New trial record
- 01 Sep 2016 Status changed from not yet recruiting to recruiting.